The active pharmaceutical ingredient (API) size distribution within the final formulation of a drug product is critical as it relates to bioavailability, rates of absorption, and stability of that…
Part of USDA requirements for in vitro bioequivalence testing is particle size distribution and agglomerate analysis of the budesonide suspension in the ampoules of both the generic product for submission…
Drug release speed is determined by the complex relationships between the polymer matrix used, the layer thickness, membrane permeability, if any, and the content and concentration of drug. When…
Learn more about Gateway Analytical's fiber analysis and discrimination using raman spectroscopy.
Authors & ContributorsRebekah ByrneJuly 22, 2013
Authors & ContributorsDavid ExlineJune 05, 2018
In our industry, quality control and process optimization are paramount. Container Closure Integrity Testing (CCIT) plays a pivotal role in maintaining the integrity of packaging and safeguarding product quality. At…
Foreign particulate matter in drug products is a common problem in the pharmaceutical industry that can have major impacts on pharmaceutical companies, from both financial and safety aspects. While…